Iatro Pharma And Biotech Limited

Pharmaceutical company specializing in manufacturing and distributing various types of medicines for human healthcare.

2005 | Pune, Maharashtra (India) | Active
Last Updated:

Iatro Pharma And Biotech Profile

Key Indicators

  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 4.58 Cr
  • Company Age 19 Year, 10 Months
  • Last Filing with ROC 31 Mar 2022
  • Satisfied Charges ₹ 6.00 Cr
  • Revenue Growth %
  • Ebitda
  • Net Worth -0.03%
  • Total Assets -15387.97%

About Iatro Pharma And Biotech

Iatro Pharma And Biotech Limited (IPABL) is a Public Limited Indian Non-Government Company incorporated in India on 15 July 2005 and has a history of 19 years and ten months. Its registered office is in Pune, Maharashtra, India.

The Company is engaged in the Life Sciences Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 4.58 Cr.

The company has closed loans amounting to ₹6.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

Anilkumar Shah, Ajit Shah, and Sharad Shah serve as directors at the Company.

Company Details

  • Location

    Pune, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24232PN2005PLC021025

  • Company No.

    021025

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    15 Jul 2005

  • Date of AGM

    30 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Life Sciences
Company report

Iatro Pharma And Biotech Limited

Explore comprehensive data for Iatro Pharma And Biotech Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Iatro Pharma And Biotech?

Board Members (3)

NameDesignationAppointment DateStatus
Anilkumar Shah Country flag representing In Director 30-Mar-2010Current
Ajit Shah Country flag representing In Director 31-Mar-2019Current
Sharad Shah Country flag representing In Director 30-Mar-2010Current

Financial Performance of Iatro Pharma And Biotech.

Iatro Pharma And Biotech Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.03%.

Iatro Pharma And Biotech revenue growth over time
Iatro Pharma And Biotech profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
-15387.97%
Profit or Loss
Net Worth
-0.03%
EBITDA

What is the Ownership and Shareholding Structure of Iatro Pharma And Biotech?

In 2019, Iatro Pharma And Biotech had a promoter holding of 8.48% and a public holding of 91.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹6.00 Cr

Charges Breakdown by Lending Institutions

  • Bank Of India : 6.00 Cr

Latest Charge Details

DateLenderAmountStatus
01 Nov 2006Bank Of India₹6.00 CrSatisfied

How Many Employees Work at Iatro Pharma And Biotech?

Unlock and access historical data on people associated with Iatro Pharma And Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Iatro Pharma And Biotech Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Iatro Pharma And Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iatro Pharma And Biotech's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Iatro Pharma And Biotech

Recent activity within the organization

  • Annual General Meeting

    Iatro Pharma And Biotech Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

  • Balance Sheet

    Iatro Pharma And Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune.

  • Director Appointment

    Ajit Ratilal Shah was appointed as a Director was appointed as a Director on 31 Mar 2019 & has been associated with this company since 6 years 1 month .

  • Charges

    A charge registered on 01 Nov 2006 via Charge ID 10024591 with Bank Of India was fully satisfied on 29 May 2014.

  • Director Appointment

    Anilkumar Ratilal Shah was appointed as a Director was appointed as a Director on 30 Mar 2010 & has been associated with this company since 15 years 1 month .

  • Director Appointment

    Sharad Babulal Shah was appointed as a Director was appointed as a Director on 30 Mar 2010 & has been associated with this company since 15 years 1 month .

Frequently asked questions

  • What is the Incorporation or founding date of Iatro Pharma And Biotech Limited?

    Iatro Pharma And Biotech Limited was incorporated on 15 Jul 2005.

  • What is authorized share capital and paid-up capital of Iatro Pharma And Biotech Limited?

    The authorized share capital of Iatro Pharma And Biotech Limited is ₹ 7.00 Cr and paid-up capital is ₹ 4.58 Cr.

  • Who are the current board members & directors of Iatro Pharma And Biotech Limited?

    Currently 3 directors are associated with Iatro Pharma And Biotech Limited.

    • Anilkumar Ratilal Shah
    • Ajit Ratilal Shah
    • Sharad Babulal Shah

  • What is the registered address of Iatro Pharma And Biotech Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Iatro Pharma And Biotech Limited is Sonigra Chambers Market Yard Road Gultekdi India, Pune, Maharashtra, 411037.

  • What is the corporate identification number (CIN) and company number of Iatro Pharma And Biotech Limited?

    The corporate identification number (CIN) of Iatro Pharma And Biotech Limited is U24232PN2005PLC021025 and the company number is 021025 as per Ministry of Corporate Affairs (MCA).

  • What change has been observed in the net worth of Iatro Pharma And Biotech Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Iatro Pharma And Biotech Limited has experienced an downturn of -0.03%.

  • When was the last Balance Sheet of Iatro Pharma And Biotech Limited filed with the ROC?

    The most recent Balance Sheet for Iatro Pharma And Biotech Limited was filed with the ROC on 31 Mar 2022.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Biotechnology